Vontobel Holding
REGN icon

Vontobel Holding’s Regeneron Pharmaceuticals REGN Stock Holding History

Vontobel Holding’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.7M Buy
33,169
+4,375
+15% +$2.98M 0.07% 232
2026
Q1 		$22.2M Buy
28,794
+15,251
+113% +$11.7M 0.08% 198
2025
Q4 		$10.5M Buy
13,543
+3,180
+31% +$2.16M 0.03% 283
2025
Q3 		$5.83M Buy
10,363
+2,861
+38% +$1.62M 0.02% 352
2025
Q2 		$3.94M Buy
7,502
+163
+2% +$91K 0.01% 401
2025
Q1 		$4.65M Buy
7,339
+881
+14% +$606K 0.02% 328
2024
Q4 		$4.6M Buy
6,458
+2,322
+56% +$1.95M 0.02% 321
2024
Q3 		$4.35M Sell
4,136
-267
-6% -$297K 0.01% 340
2024
Q2 		$4.63M Buy
4,403
+683
+18% +$662K 0.02% 315
2024
Q1 		$3.58M Sell
3,720
-1,095
-23% -$1.04M 0.03% 362
2023
Q4 		$4.23M Sell
4,815
-3,855
-44% -$3.17M 0.04% 325
2023
Q3 		$7.14M Buy
8,670
+1,665
+24% +$1.31M 0.07% 246
2023
Q2 		$5.03M Sell
7,005
-101
-1% -$77.9K 0.04% 300
2023
Q1 		$5.84M Sell
7,106
-988
-12% -$745K 0.05% 267
2022
Q4 		$5.77M Buy
8,094
+2,167
+37% +$1.6M 0.06% 264
2022
Q3 		$4.08M Sell
5,927
-438
-7% -$276K 0.05% 291
2022
Q2 		$3.8M Sell
6,365
-1,186
-16% -$771K 0.04% 283
2022
Q1 		$5.23M Sell
7,551
-4,197
-36% -$2.66M 0.05% 279
2021
Q4 		$7.55M Sell
11,748
-1,616
-12% -$994K 0.06% 225
2021
Q3 		$8.09M Buy
13,364
+551
+4% +$342K 0.07% 200
2021
Q2 		$7M Sell
12,813
-1,230
-9% -$623K 0.06% 226
2021
Q1 		$6.64M Buy
14,043
+820
+6% +$399K 0.05% 218
2020
Q4 		$6.54M Buy
+13,223
New +$7.14M 0.04% 234

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Vontobel Holding's REGN Position: Q2 2026 in Review

Vontobel Holding increased its Regeneron Pharmaceuticals (REGN) stake by 15% in Q2 2026, buying an estimated $2.98M and bringing the position to 33,169 shares worth $20.7M. The position accounts for 0.07% of the portfolio, ranked #232.

Vontobel Holding first reported a position in REGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $22.2M in Q1 2026. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Vontobel Holding held 33,169 shares of Regeneron Pharmaceuticals worth $20.7M as of Q2 2026.
  • Vontobel Holding bought 4,375 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.98M.
  • Regeneron Pharmaceuticals made up 0.07% of Vontobel Holding's portfolio in Q2 2026, its #232 holding.
  • Vontobel Holding first reported a position in Regeneron Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Vontobel Holding's Regeneron Pharmaceuticals position peaked at $22.2M in Q1 2026.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.